Concepedia

Author

Iris De Bruijn

Sanofi (France)

Also Known As

De Bruijn, Iris, I. de Bruijn, Iris De Bruijn, Iris De Bruijn, Iris de Bruijn

20

Publications

310

Citations

9

H-Index

23

Concepts

All Affiliations

Sanofi (France)Sanofi (United States)
ID

About

Iris De Bruijn is an author at Sanofi (France) specializing in influenza vaccines, vaccination, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

80

2

Education

1

1

64

3

Engineering

1

1

64

4

Data Science

1

1

64

5

Epidemiology

1

1

19

Iris De Bruijn

×

6

Publications

234

Citations

6

H-Index

YearCitations

A simple method to evaluate the reliability of OWAS observations

Iris De Bruijn, Josephine Engels, J.W.J. van der Gulden

Applied Ergonomics

1998

64

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly

Iris De Bruijn, Ingo Meyer, Lisya Gerez,

Vaccine

2007

61

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Stéphanie Pépin, Martin Dupuy, Charissa Borja-Tabora,

Vaccine

2018

54

Antibody-mediated NK cell activation as a correlate of immunity against influenza infection

Carolyn M. Boudreau, John S. Burke, Ashraf S. Yousif,

Nature Communications

2023

22

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China

Feng Zhu, Wei-Zhong Zhou, Hongxing Pan,

Vaccine

2008

19

Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial

Rosalind Hollingsworth, Arto A. Palmu, Stéphanie Pépin,

American Heart Journal

2021

14

Page 1